Given that we employed a syngeneic mouse breast cancer model to initiate our studies, we examined this possibility and found that GPNMB/OA expression was able to promote the growth of 66cl4 cells in both an immunocompetent and immunocompromised background. This evidence concerns the gene GPNMB and breast carcinoma.